There should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacy

Enterococcal Bacteremia Is Associated With Increased Risk of Mortality in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

(2012) J. Vydra et al.   CLINICAL INFECTIOUS DISEASES

Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

(2012) Ying Taur et al.   CLINICAL INFECTIOUS DISEASES

Overcoming the challenges to developing new antibiotics

(2012) David M Shlaes et al.   CURRENT OPINION IN PHARMACOLOGY

Improving known classes of antibiotics: an optimistic approach for the future

(2012) Karen Bush   CURRENT OPINION IN PHARMACOLOGY

Healthcare-Associated Infection and Hospital Readmission

(2012) Carley B. Emerson et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy

(2011) Cheol-In Kang et al.   ANNALS OF HEMATOLOGY

The Challenges of Antimicrobial Drug Resistance in Greece

(2011) S. Miyakis et al.   CLINICAL INFECTIOUS DISEASES

Challenges of Antibacterial Discovery

(2011) L. L. Silver   CLINICAL MICROBIOLOGY REVIEWS

Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study

(2011) G. Samonis et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Long-term carriage of NDM-1-producing Escherichia coli

(2011) L. Poirel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response

(2011) T. R. Walsh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study

(2011) Timothy R Walsh et al.   LANCET INFECTIOUS DISEASES

Tackling antibiotic resistance

(2011) Karen Bush et al.   NATURE REVIEWS MICROBIOLOGY

The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020

(2010)   CLINICAL INFECTIOUS DISEASES

Global spread of New Delhi metallo-β-lactamase 1

(2010) Laurent Poirel et al.   LANCET INFECTIOUS DISEASES

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

(2010) Karthikeyan K Kumarasamy et al.   LANCET INFECTIOUS DISEASES

Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock

(2009) Anand Kumar et al.   CHEST

Vancomycin Dosage Optimization in Patients with Malignant Haematological Disease by Pharmacokinetic/Pharmacodynamic Analysis

(2009) Maria del Mar Fernández de Gatta et al.   CLINICAL PHARMACOKINETICS

Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia

(2009) Abraham Borer et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

High incidence of methicillin-resistantStaphylococcus aureussepsis and death in patients with febrile neutropenia at Royal Darwin Hospital

(2009)   INTERNAL MEDICINE JOURNAL

Bacteraemia due to extended-spectrum  -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

(2009) C. Gudiol et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum β-lactamase-producing organisms

(2009) M.E. Falagas et al.   JOURNAL OF HOSPITAL INFECTION

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies

(2008) Gopi Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

It's Time for a Change in Practice: Reducing Antibiotic Use Can Alter Antibiotic Resistance

(2008) Cindy R. Friedman et al.   JOURNAL OF INFECTIOUS DISEASES

Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

(2008) Louis B. Rice   JOURNAL OF INFECTIOUS DISEASES

Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern

(2008) Patrick G. Morris et al.   SUPPORTIVE CARE IN CANCER

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES